Eventide Asset Management, LLC Axsome Therapeutics, Inc. Transaction History
Eventide Asset Management, LLC
- $5.26 Billion
- Q2 2025
A detailed history of Eventide Asset Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 725,672 shares of AXSM stock, worth $76.4 Million. This represents 1.44% of its overall portfolio holdings.
Number of Shares
725,672
Previous 744,850
2.57%
Holding current value
$76.4 Million
Previous $86.9 Million
12.8%
% of portfolio
1.44%
Previous 1.84%
Shares
6 transactions
Others Institutions Holding AXSM
# of Institutions
404Shares Held
37.4MCall Options Held
537KPut Options Held
602K-
Vanguard Group Inc Valley Forge, PA3.95MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$347 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$178 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$160 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$120 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.51B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...